Beijing Huicheng Ruixiang Pharmaceutical Biotechnology

Beijing Huicheng Ruixiang Pharmaceutical Biotechnology is a contract research organization (CRO) and pharmaceutical technology provider based in Beijing, China. Established in 2011, the company specializes in the research, development, and technical transfer of small molecule drugs and high-end chemical intermediates. Their core services include custom synthesis, process optimization, and medicinal chemistry support for pharmaceutical enterprises globally. The company maintains a strong focus on the synthesis of active pharmaceutical ingredients (APIs) and intermediates for various therapeutic areas, including cardiovascular and infectious diseases. Operating primarily as a service-oriented entity, they facilitate the transition of drug candidates from laboratory-scale synthesis to pilot and commercial production.